| Name | Title | Contact Details |
|---|
Synovis Interventional Solutions is a Circle Pines, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grapevine Executive Recruiters is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the Company`s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.
Advanced Reimbursement Management offers a suite of services encompassing Medicaid reimbursement. These service lines include: Medicaid Eligibility Assistance Services – ARM provides both on-site team members to assist with I/P and O/P enrollment of your Self Pay Patients in Medicaid as well as centralized eligibility support team members who do follow up work from our central business office. Accounts Receivables Management – ARM handles a variety of services from initial Medicaid claims billing to follow-up of aged claims at 60,90,120+ days. We use our clinical audit nursing staff to do our own in house reviews when submitting claims for reconsideration. This is an included part of the service at no extra charge. Clinical Auditing Services – ARM provides a variety of clinical auditing services in addition to claims review as part of A/R management. This includes RACs, Defense Audits (all payers), Stop Loss / Carve Out, Charge Hold / Lost Charge. In all situations, ARM provides trending feedback to the hospital in an effort to provide long term solutions. ARM can do both hourly pricing or contingency rate pricing, depending on your preference. Post Payment Review (Zero Balance) – ARM can review all of your Medicaid claims for variance from expected reimbursement amounts, and provide detailed trending, The best part is that we are budget positive because this is truly “found money”
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.